Off-label drug database
Grosjean, J.; Letord, C.; Zana, I.; Advenier-Iakovlev, E.; Duclos, C.; Krebs, M.-O.; Charlet, J.; Darmoni, S. J.
Show abstract
BackgroundMany drugs are still being prescribed in a "off-label mode" and especially in psychiatry. Off-label prescription situations may vary depending on several factors and such practice is not well identifiable in the literature. Methods: A new public academic drug database has been recently created and is able to contain off-label indications, especially in psychiatry in the context of the PSYHAMM French research project. For each situation, bibliographic references have been collected to make the scientific information available to all. Results: this new off-label drug database contains more than 18,154 lines. It is freely available at https://www.hetop.eu/hetop/medicaments. Several off-label usages have been formally described and the system is extensible to all drugs and all specialties. Conclusion: An off-label drug database can be a valuable tool for health professionals and students.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Explainable AI enables clinical trial patient selection to retrospectively improve treatment effects in schizophrenia 90%
- Therapeutic Monoclonal Antibodies Repurposing in Oncology via IMGT/mAb-KG Embeddings 89%
- On the predictability of postoperative complications for cancer patients: a Portuguese cohort study 89%
Similar papers in this journal
Similar papers in this journal
- Real-world observation on response to cholinesterase inhibitors or selective serotonin reuptake inhibitors prescribed to outpatients with dementia using electronic medical records 90%
- Pharmacokinetics of caffeine: A systematic analysis of reported data for application in metabolic phenotyping and liver function testing 90%
- Primary Target Prediction of Bioactive Molecules from Chemical Structure 90%
Similar papers in this journal
- Determining prescriptions in electronic health care (EHR) data: methods for development of standardised, reproducible drug codelists 93%
- Transforming Estonian health data to the Observational Medical Outcomes Partnership (OMOP) Common Data Model: lessons learned 92%
- Framework for Identifying Drug Repurposing Candidates from Observational Healthcare Data 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.